Press release
Kidney Cancer Diagnostics And Therapeutics Market Insights 2025-2034: Growth Forecast and Strategic Priorities
Kidney Cancer Diagnostics And Therapeutics
Kidney Cancer Diagnostics And Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for kidney cancer diagnostics and therapeutics has significantly expanded in the past few years. The market, estimated at $4.1 billion in 2024, is projected to increase to $4.32 billion in 2025, marking a compound annual growth rate (CAGR) of 5.4%. This substantial growth during the historical timeframe is the result of advancements in molecular biology research, clinical trials, new drug developments, surgical innovations, genetic findings, and improvements in healthcare access.
Kidney Cancer Diagnostics And Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
Predictions indicate a promising expansion for the kidney cancer diagnostics and therapeutics market in the upcoming years. By 2029, the market is expected to reach $5.68 billion, with a compound annual growth rate (CAGR) of 7.0%. This potential growth is underpinned by several factors such as advances in biomarker research, genomic sequencing, telemedicine, and precision medicine, alongside the implementation of rapid diagnostic technologies. The forecast period also foresees significant trends like the adoption of palliative care integration, comprehensive survivorship care, lifestyle and nutrition intervention, wide application of radiomics, and increasing acceptance of liquid biopsies.
View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-diagnostics-and-therapeutics-global-market-report
What Are the Drivers Transforming the Kidney Cancer Diagnostics And Therapeutics Market?
It is anticipated that the growth of the kidney cancer diagnostics and therapeutics market will be propelled by the rising incidence of kidney cancer. This disease is characterized by abnormal cell changes and unchecked growth in one or both kidneys, resulting in a renal cortical tumor. The significance of kidney cancer diagnostics and therapeutics is underscored by their advantages, including early disease detection, precise diagnosis, personalized medicine, treatment choice, and tracking. For example, the American Society of Clinical Oncology (ASCO), a US-based non-profit committed to cancer care, estimates that in the United States, 81,800 people (52,360 men and 29,440 women) will be diagnosed with kidney cancer in March 2023. Furthermore, globally, kidney cancer impacted 431,288 individuals in 2020. As such, the escalating incidence of kidney cancer is predicted to fuel the expansion of the kidney cancer diagnostics and therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11937&type=smp
What Long-Term Trends Will Define the Future of the Kidney Cancer Diagnostics And Therapeutics Market?
A key focus for leading firms in the kidney cancer diagnostics and therapeutics market is the progression of advanced renal cell carcinoma (RCC) treatments. The aim is to revolutionize treatment choices fitting the specific requirements of patients battling this diagnostic challenge. Renal cell carcinoma (RCC) research plays a pivotal role in the kidney cancer diagnostics and therapeutics realm due to its potential to generate enhanced diagnostic practices and precision therapies. Such developments heighten the chances of early diagnosis and personalized treatment for patients. Merck, a significant US-based pharmaceutical enterprise, is a case in point. In December 2023, it introduced welireg (belzutifan), the pioneer hypoxia-inducible factor-2 alpha (HIF-2a) inhibitor sanctioned for adult patients with advanced renal cell carcinoma (RCC) previously treated with PD-1 or PD-L1 inhibitors and VEGF-TKIs. This unique therapeutic category offers considerable advantages, such as improved progression-free survival and increased response rates compared to everolimus. The approval of WELIREG symbolizes an essential breakthrough in the kidney cancer diagnostics and therapeutics market, providing renewed optimism for patients with advancing disease.
Which Segments in the Kidney Cancer Diagnostics And Therapeutics Market Offer the Most Profit Potential?
The kidney cancer diagnostics and therapeutics market covered in this report is segmented -
1) By Cancer Type: Clear Cell RCC, Papillary RCC, Chromophobe RCC, Urothelial Carcinoma And Transitional Cell Carcinoma, Other Cancer Types
2) By Component: Drugs, Diagnostics
3) By Diagnostics: Biopsy, CT Scan, Nephro-Ureteroscopy, Intravenous Pyelogram, Ultrasound
4) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy
5) By End-Users: Hospitals, Pharmaceutical Labs, Genomics Laboratories
Subsegments:
1) By Clear Cell RCC: Stage I, Stage II, Stage III, Stage IV
2) By Papillary RCC: Type 1, Type 2
3) By Chromophobe RCC: Localized, Advanced
4) By Urothelial Carcinoma And Transitional Cell Carcinoma: Non-muscle invasive, Muscle invasive, Metastatic
5) By Other Cancer Types: Collecting Duct Carcinoma, Renal Medullary Carcinoma, Other rare types
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11937&type=smp
Which Firms Dominate the Kidney Cancer Diagnostics And Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the kidney cancer diagnostics and therapeutics market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Pharmaceuticals Limited, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Siemens Healthcare GmbH, Laboratory Corporation of America Holdings, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Eisai Co. Ltd., Illumina Inc., PerkinElmer Inc., Ipsen S.A, Bio-Rad Laboratories Inc., QIAGEN NV, Exelixis Inc., Myriad Genetics Inc., Invitae Corporation, Guardant Health Inc., GeneDx LLC, CD Genomics, Genpath Life Sciences Private Limited
Which Regions Offer the Highest Growth Potential in the Kidney Cancer Diagnostics And Therapeutics Market?
North America was the largest region in the kidney cancer diagnostics and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney cancer diagnostics and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11937
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Diagnostics And Therapeutics Market Insights 2025-2034: Growth Forecast and Strategic Priorities here
News-ID: 4108104 • Views: …
More Releases from The Business Research Company
2025 Skin Care Supplements Industry Trends Report: Long-Term Outlook Through 203 …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Skin Care Supplements Market Size By 2025?
In recent times, the skin care supplements market has seen a robust expansion. It is projected to elevate from $2.85 billion in 2024 to $3.06 billion in 2025, marking a compound annual growth rate (CAGR) of 7.2%. The…
Major Growth Driver Identified in 2025 Peanut Allergy Treatment Market: Driving …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Postpartum Health Supplements Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a robust expansion of the postpartum health supplements market. Its value is expected to surge from $1.38 billion in 2024 to $1.5 billion in 2025, with an average annual growth rate…
Major Growth Driver Identified in 2025 Peanut Allergy Treatment Market: Driving …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Peanut Allergy Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the peanut allergy treatment market has seen a hefty expansion. The market size is set to swell from $0.45 billion in 2024 to $0.5 billion in 2025, with a compound annual…
Rising Cases Of Cardiovascular Diseases Is Driving The Growth Of The Nuclear Med …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Nuclear Medicine Radioisotopes Market Through 2025?
In recent years, the nuclear medicine radioisotopes market has seen robust growth. Projected to increase from $8.21 billion in 2024 to $8.85 billion in 2025, it is expected to have a compound annual growth rate (CAGR)…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
